Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors

Condition:   Advanced Solid Tumor Interventions:   Drug: LY01610 ( Irinotecan hydrochloride liposome injection );   Drug: LY01610 ( Irinotecan hydrochloride liposome injection ) with 5-Fu（Fluorouracil Injection）;   Drug: Irinotecan Hydrochloride Injection（CAMPTO®） Sponsor:   Luye Pharma Group Ltd. Recruiting

Source: ClinicalTrials.gov - September 13, 2019 Category: Research Source Type: clinical trials